α1-Microglobulin (A1M) Protects Human Proximal Tubule Epithelial Cells from Heme-Induced Damage In Vitro
Open Access
- 13 August 2020
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (16) , 5825
Abstract
Oxidative stress is associated with many renal disorders, both acute and chronic, and has also been described to contribute to the disease progression. Therefore, oxidative stress is a potential therapeutic target. The human antioxidant α1-microglobulin (A1M) is a plasma and tissue protein with heme-binding, radical-scavenging and reductase activities. A1M can be internalized by cells, localized to the mitochondria and protect mitochondrial function. Due to its small size, A1M is filtered from the blood into the glomeruli, and taken up by the renal tubular epithelial cells. A1M has previously been described to reduce renal damage in animal models of preeclampsia, radiotherapy and rhabdomyolysis, and is proposed as a pharmacological agent for the treatment of kidney damage. In this paper, we examined the in vitro protective effects of recombinant human A1M (rA1M) in human proximal tubule epithelial cells. Moreover, rA1M was found to protect against heme-induced cell-death both in primary cells (RPTEC) and in a cell-line (HK-2). Expression of stress-related genes was upregulated in both cell cultures in response to heme exposure, as measured by qPCR and confirmed with in situ hybridization in HK-2 cells, whereas co-treatment with rA1M counteracted the upregulation. Mitochondrial respiration, analyzed with the Seahorse extracellular flux analyzer, was compromised following exposure to heme, but preserved by co-treatment with rA1M. Finally, heme addition to RPTE cells induced an upregulation of the endogenous cellular expression of A1M, via activation of the nuclear factor erythroid 2-related factor 2 (Nrf2)-pathway. Overall, data suggest that A1M/rA1M protects against stress-induced damage to tubule epithelial cells that, at least partly, can be attributed to maintaining mitochondrial function.Keywords
Funding Information
- Vetenskapsrådet (2014-02470, 2017-00696)
- ALF Research Grants (n/a)
- Stiftelsen för Strategisk Forskning (n/a)
- Crafoordska Foundation (n/a)
- Greta och Johan Kocks stiftelser (n/a)
- Alfred Österlund Foundation (n/a)
- Fanny Ekdahls Foundation (n/a)
- Swedish Heart-Lung Foundation (n/a)
- Guard Therapeutics International AB (n/a)
This publication has 68 references indexed in Scilit:
- Exposure to Nerve Growth Factor Worsens Nephrotoxic Effect Induced by Cyclosporine A in HK-2 CellsPLOS ONE, 2013
- Novel Hematopoietic Target Genes in the NRF2-Mediated Transcriptional PathwayOxidative Medicine and Cellular Longevity, 2013
- Sites of reactive oxygen species generation by mitochondria oxidizing different substratesRedox Biology, 2013
- Nerve growth factor: from the early discoveries to the potential clinical useJournal of Translational Medicine, 2012
- Acute kidney injuryThe Lancet, 2012
- Plasma and Urinary Heme Oxygenase-1 in AKIJournal of the American Society of Nephrology, 2012
- Up-Regulation of A1M/α1-Microglobulin in Skin by Heme and Reactive Oxygen Species Gives Protection from Oxidative DamagePLOS ONE, 2011
- Postoperative acute kidney injury is associated with hemoglobinemia and an enhanced oxidative stress responseFree Radical Biology and Medicine, 2011
- Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injuryCritical Care, 2007
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970